| Article | Date | Source |
|---|
| 3-V Biosciences raises $20M to treat Hepatitis C | January 06, 2012 | Health News - BizJournals.com |
| 3-V Biosciences Closes Preferred Stock Financing and Designates Novel Host-Factor Hepatitis C Program | January 05, 2012 | Medical Pharma - PR Newswire |
| 3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer | August 15, 2011 | Pharma News - PharmiWeb |
| 3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer | February 10, 2011 | Biotech News - PR Newswire |
| 3-V Biosciences Appoints as Chief Executive Officer | September 30, 2010 | BioSpace |
| 3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer | September 30, 2010 | Biotech News - PR Newswire |
| James F. Young Joins 3-V Biosciences Board of Directors | July 20, 2010 | Biotech News - PR Newswire |
| 3-V Biosciences puts ex-Medimmune exec on board | July 20, 2010 | Health News - BizJournals.com |
| 3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer | June 03, 2010 | Pharma News - PR Newswire |
| 3-V Biosciences names medical chief | June 03, 2010 | Health News - BizJournals.com |
| 3-V Biosciences opens new Menlo Park lab | May 13, 2010 | Health News - BizJournals.com |
| 3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations | May 13, 2010 | Biotech News - PR Newswire |
